According to our injectable drugs market report, emerging market trends in biologic medicine is positively impacting injectable drugs market. The global injectable drugs market is segmented on the basis of product type such as vaccines, insulin, conventional therapeutic and biologics. Among these segments, complex biologics segment occupies maximum revenue share of 42.5% in global injectable drugs market and is expected to maintain its dominance over the forecast period. Increasing research & development spending in healthcare industry and growing demand for drug solutions for biologics such as rheumatology, gastroenterology and haematology is likely to boost the demand for complex biologics injectable drugs in the near future. Short approval time by Food and Drug Administration (FDA) for the development of new injectable drugs in cancer treatment is accelerating the growth of global injectable drugs market. Moreover, introduction of advance vaccines such as peptide vaccines and DNA va
